These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21316226)

  • 1. Pyridyl amides as potent inhibitors of T-type calcium channels.
    Reger TS; Yang ZQ; Schlegel KA; Shu Y; Mattern C; Cube R; Rittle KE; McGaughey GB; Hartman GD; Tang C; Ballard J; Kuo Y; Prueksaritanont T; Nuss CE; Doran SM; Fox SV; Garson SL; Li Y; Kraus RL; Uebele VN; Renger JJ; Barrow JC
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1692-6. PubMed ID: 21316226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.
    Jo MN; Seo HJ; Kim Y; Seo SH; Rhim H; Cho YS; Cha JH; Koh HY; Choo H; Pae AN
    Bioorg Med Chem; 2007 Jan; 15(1):365-73. PubMed ID: 17035033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead discovery and optimization of T-type calcium channel blockers.
    Park JH; Choi JK; Lee E; Lee JK; Rhim H; Seo SH; Kim Y; Doddareddy MR; Pae AN; Kang J; Roh EJ
    Bioorg Med Chem; 2007 Feb; 15(3):1409-19. PubMed ID: 17150365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
    Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
    J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and expanded SAR of 4,4-disubstituted quinazolin-2-ones as potent T-type calcium channel antagonists.
    Schlegel KA; Yang ZQ; Reger TS; Shu Y; Cube R; Rittle KE; Bondiskey P; Bock MG; Hartman GD; Tang C; Ballard J; Kuo Y; Prueksaritanont T; Nuss CE; Doran SM; Fox SV; Garson SL; Kraus RL; Li Y; Uebele VN; Renger JJ; Barrow JC
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5147-52. PubMed ID: 20673719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
    Yang ZQ; Barrow JC; Shipe WD; Schlegel KA; Shu Y; Yang FV; Lindsley CW; Rittle KE; Bock MG; Hartman GD; Uebele VN; Nuss CE; Fox SV; Kraus RL; Doran SM; Connolly TM; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Marino MJ; Graufelds VK; DiLella AG; Reynolds IJ; Vargas HM; Bunting PB; Woltmann RF; Magee MM; Koblan KS; Renger JJ
    J Med Chem; 2008 Oct; 51(20):6471-7. PubMed ID: 18817368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of 1,3-dioxoisoindoline-5-carboxamide derivatives as T-type calcium channel blockers.
    Kim HS; Kim Y; Doddareddy MR; Seo SH; Rhim H; Tae J; Pae AN; Choo H; Cho YS
    Bioorg Med Chem Lett; 2007 Jan; 17(2):476-81. PubMed ID: 17092715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
    Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
    Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonist.
    Shipe WD; Barrow JC; Yang ZQ; Lindsley CW; Yang FV; Schlegel KA; Shu Y; Rittle KE; Bock MG; Hartman GD; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Uebele VN; Nuss CE; Connolly TM; Doran SM; Fox SV; Kraus RL; Marino MJ; Graufelds VK; Vargas HM; Bunting PB; Hasbun-Manning M; Evans RM; Koblan KS; Renger JJ
    J Med Chem; 2008 Jul; 51(13):3692-5. PubMed ID: 18540666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide core.
    Hangeland JJ; Cheney DL; Friends TJ; Swartz S; Levesque PC; Rich AJ; Sun L; Bridal TR; Adam LP; Normandin DE; Murugesan N; Ewing WR
    Bioorg Med Chem Lett; 2008 Jan; 18(2):474-8. PubMed ID: 18160281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive allosteric interaction of structurally diverse T-type calcium channel antagonists.
    Uebele VN; Nuss CE; Fox SV; Garson SL; Cristescu R; Doran SM; Kraus RL; Santarelli VP; Li Y; Barrow JC; Yang ZQ; Schlegel KA; Rittle KE; Reger TS; Bednar RA; Lemaire W; Mullen FA; Ballard JE; Tang C; Dai G; McManus OB; Koblan KS; Renger JJ
    Cell Biochem Biophys; 2009; 55(2):81-93. PubMed ID: 19582593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel potent and selective calcium-release-activated calcium (CRAC) channel inhibitors. Part 1: synthesis and inhibitory activity of 5-(1-methyl-3-trifluoromethyl-1H-pyrazol-5-yl)-2-thiophenecarboxamides.
    Yonetoku Y; Kubota H; Okamoto Y; Toyoshima A; Funatsu M; Ishikawa J; Takeuchi M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2006 Jul; 14(14):4750-60. PubMed ID: 16580212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaffold-based design and synthesis of potent N-type calcium channel blockers.
    Zamponi GW; Feng ZP; Zhang L; Pajouhesh H; Ding Y; Belardetti F; Pajouhesh H; Dolphin D; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6467-72. PubMed ID: 19815411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D pharmacophore based virtual screening of T-type calcium channel blockers.
    Doddareddy MR; Choo H; Cho YS; Rhim H; Koh HY; Lee JH; Jeong SW; Pae AN
    Bioorg Med Chem; 2007 Jan; 15(2):1091-105. PubMed ID: 17074493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers.
    Rhim H; Lee YS; Park SJ; Chung BY; Lee JY
    Bioorg Med Chem Lett; 2005 Jan; 15(2):283-6. PubMed ID: 15603940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers.
    Ku IW; Cho S; Doddareddy MR; Jang MS; Keum G; Lee JH; Chung BY; Kim Y; Rhim H; Kang SB
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5244-8. PubMed ID: 16876404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-type calcium channels inhibitors: a patent review.
    Giordanetto F; Knerr L; Wållberg A
    Expert Opin Ther Pat; 2011 Jan; 21(1):85-101. PubMed ID: 21087200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and evaluation of Ca
    Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Ertel EA; Moon R; Mawet J; Pfeifer T; Capeleto B
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5326-5331. PubMed ID: 29074257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel T-type calcium channel blockers.
    Choi JY; Seo HN; Lee MJ; Park SJ; Park SJ; Jeon JY; Kang JH; Pae AN; Rhim H; Lee JY
    Bioorg Med Chem Lett; 2007 Jan; 17(2):471-5. PubMed ID: 17064894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation into the structure-activity relationship of novel concentration dependent, dual action T-type calcium channel agonists/antagonists.
    McCalmont WF; Patterson JR; Lindenmuth MA; Heady TN; Haverstick DM; Gray LS; Macdonald TL
    Bioorg Med Chem; 2005 Jun; 13(11):3821-39. PubMed ID: 15863008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.